Fang Fang,CEO of Abimmune Biopharma, Inc., San Diego, U.S.A. She received close to $100M government grants; brought a first-in-class drug (Fludase) from a pure concept to saving over 100 lives (including infants) under the FDA emergency use authorization; received "Scientific American 50" Award. After close to 10 clinical trials, Fludase was granted “Breakthrough and Fast Track” status by the FDA for the indication of Para-Influenza for which no drug or vaccine is available.于2016年3月17-18日受邀参加了2016年皇后镇分子生物学（上海）会议，并以"From a pure concept to a first-in-class live saving drug and more”为题目，发表了精彩的演讲。
活动家是第三方嘉宾邀约平台。可根据演讲议题、会议日期、活动预算等要求，为您提供该领域内专业嘉宾演讲邀约服务，专家学者嘉宾远程视频分享发言，祝福致辞视频拍摄，网红明星艺人VCR活动录制，代言邀约，企业家国际顾问咨询服务。您可准备好活动信息后，联系电话：18911802888（王老师）（工作日9时至18时，仅邀约嘉宾出席活动，其他需求勿扰）